Correlation analysis between p16 and p53 in different breast cancer subtypes revealed that, when p16 was downregulated, only DCIS luminal-A subtypes were frequently negative for IHC p53 staining. This evidence concerns the gene CDKN2A and ductal breast carcinoma in situ.